Pregnancy complications in HIV-positive women: 11-year data from the Frankfurt HIV Cohort

HIV Medicine

Volumn 15, Issue 9, 2014, Pages 525-536

  Reitter, Anke ^a   Stucker A U ^a   Linde, R ^a   Konigs C ^a   Knecht, G ^b   Herrmann, E ^c   Schlosser R ^a   Louwen, F ^a   Haberl, A ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b Center for Infectious Diseases   (Germany)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

Gestational diabetes mellitus (GDM); High risk pregnancy; Highly active antiretroviral therapy (HAART); HIV; Mother to child transmission (MTCT); Preterm delivery

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; FEMALE; GERMANY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MATERNAL MORBIDITY; MATERNAL MORTALITY; NEWBORN; NEWBORN MORBIDITY; NEWBORN MORTALITY; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; VAGINAL DELIVERY; VERTICAL TRANSMISSION; CD4 LYMPHOCYTE COUNT; CESAREAN SECTION; COMPLICATION; DELIVERY; ELECTIVE SURGERY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; IMMUNOLOGY; MIXED INFECTION; PATHOPHYSIOLOGY; PATIENT REFERRAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREMATURE BIRTH; PREVENTION AND CONTROL; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS; VIRUS LOAD;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CESAREAN SECTION; COHORT STUDIES; COINFECTION; DELIVERY, OBSTETRIC; ELECTIVE SURGICAL PROCEDURES; FEMALE; GERMANY; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREMATURE BIRTH; REFERRAL AND CONSULTATION; SUBSTANCE-RELATED DISORDERS; VIRAL LOAD;

EID: 84925944938     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/hiv.12142     Document Type: Article

References (34)

1. UNAIDS: UNAIDS Report on the global AIDS epidemic 2012. Available at http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/gr2012/20121120_UNAIDS_Global_Report_2012_en.pdf (accessed January 2013).
2. European Centre for Disease Prevention and Control. HIV/AIDS surveillance in Europe 2011. Available at http://ecdc.europa.eu/en/publications/publications/20121130-annual-hiv-surveillance-report.pdf (accessed January 2012).
3. Warszawski J, Tubiana R, Le Chenadec J etal. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort. AIDS 2008; 22: 289-299.
4. Aebi-Popp K, Mulcahy F, Glass TR etal.; European Collaborative Study in EuroCoord; Swiss Mother & Child HIV Cohort Study. Missed opportunities among HIV-positive women to control viral replication during pregnancy and to have a vaginal delivery. J Acquir Immune Defic Syndr 2013; 64: 58-65.
5. Townsend CL, Cortina-Borja M, Peckham CS, de Ruiter A, Lyall H, Tookey PA. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS 2008; 22: 973-981.
6. Townsend C, Schulte J, Thorne C etal. Antiretroviral therapy and preterm delivery-a pooled analysis of data from the United States and Europe. BJOG 2010; 117: 1399-1410.
7. Grosch-Woerner I, Puch K, Maier RF etal. Increased rate of prematurity associated with antenatal antiretroviral therapy in a German/Austrian cohort of HIV-1-infected women. HIV Med 2008; 9: 6-13.
8. Knapp KM, Brogly SB, Muenz DG etal. Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals. Pediatr Infect Dis J 2012; 31: 164-170.
9. Mandelbrot L, Jasseron C, Ekoukou D etal. Amniocentesis and mother-to-child human immunodeficiency virus transmission in the Agence Nationale de Recherches sur le SIDA et les Hepatites Virales French Perinatal Cohort. Am J Obstet Gynecol 2009; 200: 160.e1-160.
10. Sibiude J, Warszawski J, Tubiana R etal. Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost? Clin Infect Dis 2012; 54: 1348-1360.
11. Sturt AS, Dokubo EK, Sint TT. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women. Cochrane Database Syst Rev 2010; 3: CD008440.
12. German HIV Pregnancy Registry. Available at http://www.daignet.de/site-content/hiv-therapie/leitlinien-1 (accessed 20 February 2014).
13. Boyd PA, Haeusler M, Barisic I. EUROCAT Report 9: surveillance of congenital anomalies in Europe 1980-2008. Birth Defects Res A Clin Mol Teratol 2011; 91 (Suppl 1): S1.
14. Khoshnood B, Greenlees R, Loane M, Dolk H. Paper 2: EUROCAT public health indicators for congenital anomalies in Europe. Birth Defects Res A Clin Mol Teratol 2011; 91 (Suppl 1): S16-S22.
15. Reitter A, Stucker AU, Buxmann H etal. Prenatal ultrasound screening for fetal anomalies and outcomes in high-risk pregnancies due to maternal HIV infection: a retrospective study. Infect Dis Obstet Gynecol 2013; 2013: 208482.
16. Buchholz B, Marcus U, Beichert M etal. German-Austrian recommendations for HIV-therapy in pregnancy-common declaration of The German AIDS-society (DAIG), The Austrian AIDS-society (OEAG) as well as The Robert-Koch Institute Berlin (RKI), The German Association of Physicians specialized in HIV Care (DAGNAE), The German Society of Pediatric and Youth Medicine (DGKJ), The German AIDS Pediatric Association (PAAD), The German Society of Obstetrics and Gynecology (DGGG), The National Reference Center for Retroviruses (NRZ), German AIDS Assistance (DAH). Eur J Med Res 2002; 7: 417-433.
17. Buchholz B, Beichert M, Marcus U etal. German-Austrian recommendations for HIV-therapy in pregnancy and in HIV-exposed newborn - update 2005. Eur J Med Res 2006; 11: 359-376.
18. Buchholz B, Beichert M, Marcus U etal. German-Austrian recommendations for HIV1-therapy in pregnancy and in HIV1-exposed newborn, update 2008. Eur J Med Res 2009; 14: 461-479.
19. German-Austrian recommendations for HIV treatment during pregnancy and for newborns exposed to HIV-Update 2008. Dtsch Med Wochenschr 2009; 134 (Suppl 1): S40-S54. Deutsch-Osterreichische Empfehlungen zur HIV-Therapie in der Schwangerschaft und bei HIV-exponierten Neugeborenen-Update 2008. ger.
20. Boer K, Nellen JF, Patel D etal. The AmRo study: pregnancy outcome in HIV-1-infected women under effective highly active antiretroviral therapy and a policy of vaginal delivery. BJOG 2007; 114: 148-155.
21. (DDG) GSoD-DDG. 2011. Available at http://www.awmf.org/leitlinien/detail/ll/057-008.html (accessed 20 February 2014).
22. Diagnostic and therapy of hypertensive disorders in Pregnancy. AWMF. 2011. Available at http://www.awmf.org/leitlinien/detail/ll/015-018.html (accessed 20 February 2014).
23. Gallot D, Guibourdenche J, Sapin V etal. Which biological test to confirm rupture of membranes? J Gynecol Obstet Biol Reprod (Paris) 2012; 41: 115-121.
24. Voigt MFC, Olbertz D, Hartmann K, Rochow N, Renken C, Schneider KTM. Analyse des Neugeborenenkollektivs der Bundesrepublik Deutschland Analysis of the Neonatal Collective in the Federal Republic of Germany. Geburtshilfe Frauenheilkd 2006; 66: 956-970.
25. Heinonen OP, Slone D, Shapiro S. Birth Defects and Drugs in Pregnancy. Littleton, MA, PSG Publishing, 1977.
26. Aebi-Popp K, Lapaire O, Glass TR etal. Pregnancy and delivery outcomes of HIV infected women in Switzerland 2003-2008. J Perinat Med 2010; 38: 353-358.
27. Briand N, Mandelbrot L, Le Chenadec J etal. No relation between in-utero exposure to HAART and intrauterine growth retardation. AIDS 2009; 23: 1235-1243.
28. Boer K, England K, Godfried MH, Thorne C. Mode of delivery in HIV-infected pregnant women and prevention of mother-to-child transmission: changing practices in Western Europe. HIV Med 2010; 11: 368-378.
29. Gingelmaier A, Hollwitz B, Casteleyn S etal. Course of pregnancies and fetal outcome of 599 HIV-exposed pregnancies in german reference centers 1999-2003. Geburtshilfe Frauenheilkd 2005; 65: 1058-1063.
30. Gonzalez-Tome MI, Ramos Amador JT, Guillen S etal. Gestational diabetes mellitus in a cohort of HIV-1 infected women. HIV Med 2008; 9: 868-874.
31. Schulte J, Dominguez K, Sukalac T, Bohannon B, Fowler MG. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004. Pediatrics 2007; 119: e900-e906.
32. Porip N, Dudenhausen JW, Ginglemaier A, Weizaecker K. HIV Testing during prenatal care-comparison of the situation before and after the update of the german prenatal care guidelines in December 2007. Geburtshilfe Frauenheilkd 2010; 70: 294-297.
33. Metzger BE, Lowe LP, Dyer AR etal. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991-2002.
34. Iqbal SN, Kriebs J, Harman C etal. Predictors of fetal growth in maternal HIV disease. Am J Perinatol 2010; 27: 517-523.